Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial Article

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Nishio, Makoto; Barlesi, Fabrice; West, Howard; Ball, Simon; Bordoni, Rodolfo; Cobo, Manuel; Longeras, Pascale Dubray; Goldschmidt, Jerome, Jr.; Novello, Silvia; Orlandi, Francisco; Sanborn, Rachel E.; Szalai, Zsuzsanna; Ursol, Grigoriy; Mendus, Diana; Wang, Lijia; Wen, Xiaohui; McCleland, Mark; Hoang, Tien; Phan, See; Socinski, Mark A.

authors

Publication Date

  • April 1, 2021

webpage

published in

category

keywords

  • Atezolizumab
  • Lung cancer
  • Non-small cell
  • Nonsquamous

start page

  • 653

end page

  • 664

volume

  • 16

issue

  • 4